Glucagon-like peptide-1 receptor and sarcoglycan delta genetic variants can affect cardiovascular risk in chronic kidney disease patients under hemodialysis.

Annalisa TerranegraTeresa ArcidiaconoLorenza MacrinaCaterina BrasacchioFrancesca PivariAlessandra MingioneSara TomeiMassimo MezzavillaLee SilcockMario Gennaro CozzolinoNicola PalmieriFerruccio ConteMarcella SirtoriAlessandro RubinacciLaura SoldatiGiuseppe Vezzoli

Published in: Clinical kidney journal (2020)

This study identified GLP1R rs10305445 and SCGD rs145292439 as potential genetic markers that may explain the higher risk of CVD in hemodialysis patients.

Keyphrases

end stage renal disease
chronic kidney disease
peritoneal dialysis
ejection fraction
prognostic factors
genome wide
dna methylation
patient reported outcomes
climate change
risk assessment
patient reported